TuHURA Biosciences, Inc.
HURA
Positions held
Your positionsHURA isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $122.99M | Enterprise value | $131.45M | Trailing P/E | — | Forward P/E | -3.19 |
| PEG | — | Price / book | 6.75 | Beta | — | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -1.6% | ROA | -58.4% | Debt / equity | 0.50 |
| Current ratio | 0.18 | Free cash flow | -$18.28M | Analyst recommendation | none | Mean target | $8.04 |
| 52w high | $3.43 | 52w low | $0.41 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$9.2M | -$7.5M | -$6.8M | -$7.1M | -$9.5M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$8.8M | -$7.5M | -$4.4M | -$6.6M | -$6.5M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$30.1M | -$21.7M | -$29.3M | -$9.4M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$27.3M | -$17.2M | -$13.2M | -$9.7M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-14 · TuHURA Biosciences Says FDA Clears Phase 1b Trial of TBS-2025 in Acute Myeloid Leukemia
2026-09-08 · TuHURA Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
2026-08-26 · HURA: Milestone Progression Over Next 12 Months
2026-08-14 · TuHURA Biosciences Highlights Phase III IFx Push, AML Trial Plans at Canaccord
2026-08-14 · TuHURA Biosciences Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
2026-07-22 · TuHURA Biosciences to Present at Canaccord Genuity's 46th Annual Growth Conference
Price (daily)
Full chart · RSI · MACD · patterns